Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maarten Van Roy
Observed names:
M Van Roy,
M. Roy,
M. Van Roy,
Maarten van Roy,
Van Roy, Maarten
Institution:
Ablynx (Belgium)
Observed institutions:
Ablynx (Belgium),
University Hospitals Bristol NHS Foundation Trust,
Vlaams Instituut voor Biotechnologie,
Ghent University
OpenAlex ID:
A5113557332
Animal models in translational medicine: Validation and prediction
2014
·
Tinneke Denayer
, Thomas Stöhr
, et al.
·
European Journal of Molecular & Clinical Medicine
·
568
The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis
2015
·
Maarten Van Roy
, Cedric Ververken
, et al.
·
Arthritis Research & Therapy
·
203
PDF
Llama-derived Single Variable Domains (Nanobodies) Directed against Chemokine Receptor CXCR7 Reduce Head and Neck Cancer Cell Growth in Vivo
2013
·
David Maussang
, Azra Mujić-Delić
, et al.
·
Journal of Biological Chemistry
·
175
PDF
Safe TNF-based antitumor therapy following p55TNFR reduction in intestinal epithelium
2013
·
Filip Van Hauwermeiren
, Marietta Armaka
, et al.
·
Journal of Clinical Investigation
·
84
PDF
Reperfusion of cerebral artery thrombosis by the GPIb–VWF blockade with the Nanobody ALX-0081 reduces brain infarct size in guinea pigs
2013
·
Stefania Momi
, Michela Tantucci
, et al.
·
Blood
·
78
Human Epidermal Growth Factor Receptor 3–Specific Tumor Uptake and Biodistribution of89Zr-MSB0010853 Visualized by Real-Time and Noninvasive PET Imaging
2017
·
Frank J. Warnders
, Anton G.T. Terwisscha van Scheltinga
, et al.
·
Journal of Nuclear Medicine
·
49
PDF
Neutralization of Human Interleukin 23 by Multivalent Nanobodies Explained by the Structure of Cytokine–Nanobody Complex
2017
·
Aline Desmyter
, Silvia Spinelli
, et al.
·
Frontiers in Immunology
·
48
PDF
Protection of Zinc against Tumor Necrosis Factor–Induced Lethal Inflammation Depends on Heat Shock Protein 70 and Allows Safe Antitumor Therapy
2007
·
Wim Van Molle
, Maarten Van Roy
, et al.
·
Cancer Research
·
36
Structure elucidation of a human melanocortin-4 receptor specific orthosteric nanobody agonist
2024
·
Thomas Fontaine
, Andreas Busch
, et al.
·
Nature Communications
·
28
PDF
Involvement of specific matrix metalloproteinases during tumor necrosis factor/IFNγ–based cancer therapy in mice
2007
·
Maarten Van Roy
, Philippe Van Lint
, et al.
·
Molecular Cancer Therapeutics
·
11
The use of tissue inhibitors of matrix metalloproteinases to increase the efficacy of a tumor necrosis factor/interferonγ antitumor therapy
2007
·
M Van Roy
, B Wielockx
, et al.
·
Cancer Gene Therapy
·
9
FRI0021 Alx-0061, an anti-IL-6r nanobody® for therapeutic use in rheumatoid arthritis, demonstrates in vitro a differential biological activity profile as compared to tocilizumab
2013
·
M. Van Roy
, A. Van de Sompel
, et al.
·
Annals of the Rheumatic Diseases
·
8
ALX-0141, an anti-rank-L targeting nanobody®, increases bone mass in cynomolgus monkeys
2012
·
R. Samadfam⁎
, S. Jacobs
, et al.
·
Bone
·
4
AB0098 A unique subset of rheumatoid arthritis defined by a distinct serum cytokine profile
2012
·
M.H. Al-Mossawi
, M. Roy
, et al.
·
Annals of the Rheumatic Diseases
·
1
Nonclinical safety assessment of the RANK-L targeting Nanobody® ALX-0141
2012
·
Sandy Jacobs
, Maarten Van Roy
, et al.
·
Toxicology Letters
·
1
Description and Mapping of the Resistance of DBA/2 Mice to TNF-Induced Lethal Shock
2007
·
Ben Wielockx
, Jan Staelens
, et al.
·
The Journal of Immunology
·
1
PDF
New Developments in the Use of Biomarkers in Translational Medicine
2015
·
Benedikte Serruys
, Thomas Stöhr
, et al.
·
Elsevier eBooks
Abstract 15828: Alx-0081, a Selective Inhibitor of the Interaction Between Platelet Gpib and Von Willebrand Factor, Prevents Ischemic Stroke in the Guinea Pig: Comparison With the Thrombolytic Rtpa.
2010
·
Stefania Momi
, Michela Tantucci
, et al.
·
Circulation
Show more works
View as search
Works count:
23
Citation count:
1,304
H-index:
10
I10-index:
10
Year
Topic
Type